MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,923,738 | +47.6% | 181,904 | +22.5% | 1.54% | +72.4% |
| Q2 2023 | $5,367,220 | +12.4% | 148,553 | +15.7% | 0.90% | -2.5% |
| Q1 2023 | $4,774,135 | +57.6% | 128,406 | +92.1% | 0.92% | +56.7% |
| Q4 2022 | $3,028,792 | -27.1% | 66,846 | +12.3% | 0.59% | -28.4% |
| Q3 2022 | $4,157,000 | -9.7% | 59,516 | -13.3% | 0.82% | -11.7% |
| Q2 2022 | $4,606,000 | -6.4% | 68,613 | +14.7% | 0.93% | +6.3% |
| Q1 2022 | $4,920,000 | -55.8% | 59,837 | -21.1% | 0.87% | -47.8% |
| Q4 2021 | $11,125,000 | +2366.7% | 75,837 | +2872.8% | 1.67% | +4305.3% |
| Q3 2021 | $451,000 | +14.8% | 2,551 | +4.9% | 0.04% | +18.8% |
| Q2 2021 | $393,000 | -97.1% | 2,431 | -96.9% | 0.03% | -96.9% |
| Q1 2021 | $13,547,000 | -16.2% | 79,081 | +7.4% | 1.03% | -9.9% |
| Q4 2020 | $16,174,000 | +13.0% | 73,638 | -41.2% | 1.14% | -13.2% |
| Q2 2020 | $14,310,000 | +151.2% | 125,336 | +69.1% | 1.31% | +20.2% |
| Q1 2020 | $5,696,000 | – | 74,100 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |